MAPT and Alzheimer disease: When combined with magnetic resonance imaging (MRI), functional MRI (fMRI), and PET studies of brain glucose utilization, CSF assays of Tau, pTau and AβPP-Aβ correlate well with intermediate and late stages of AD [33,40].